These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 3080046)

  • 21. Comparative studies of laparoscopy, histology and gray-scale echotomography in diffuse diseases of the liver.
    Vogel HM; Scherer K; Look D
    Endoscopy; 1980 Jul; 12(4):166-74. PubMed ID: 6447063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.
    Palmentieri B; de Sio I; La Mura V; Masarone M; Vecchione R; Bruno S; Torella R; Persico M
    Dig Liver Dis; 2006 Jul; 38(7):485-9. PubMed ID: 16716779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases--comparison of sonography and liver histology].
    Steinmaurer HJ; Jirak P; Walchshofer J; Clodi PH
    Ultraschall Med; 1984 Jun; 5(3):98-103. PubMed ID: 6474150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
    Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
    J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Importance of ultrasonography in the diagnosis of diffuse parenchymal disorders of the liver].
    Pirovino M; Grauer W; Götz A; Huber M; Altorfer J; Maranta E; Schmid M
    Schweiz Med Wochenschr; 1982 Apr; 112(15):525-6. PubMed ID: 7079689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
    Schneider AR; Teuber G; Kriener S; Caspary WF
    Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasonography of alcoholic liver disease with histological correlation.
    Taylor KJ; Gorelick FS; Rosenfield AT; Riely CA
    Radiology; 1981 Oct; 141(1):157-61. PubMed ID: 6270725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C.
    Zaitoun AM; Al Mardini H; Awad S; Ukabam S; Makadisi S; Record CO
    J Clin Pathol; 2001 Jun; 54(6):461-5. PubMed ID: 11376020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-invasive assessment of fatty liver].
    Egresi A; Lengyel G; Hagymási K
    Orv Hetil; 2015 Apr; 156(14):543-51. PubMed ID: 25819147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques.
    Celle G; Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Dodero M
    Dig Dis Sci; 1988 Apr; 33(4):467-71. PubMed ID: 3280274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
    Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.
    Skelly MM; James PD; Ryder SD
    J Hepatol; 2001 Aug; 35(2):195-9. PubMed ID: 11580141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Noninvasive diagnosis of fatty liver disease].
    Qu Y; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):155-7. PubMed ID: 20196962
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic morphology in obesity.
    Nasrallah SM; Wills CE; Galambos JT
    Dig Dis Sci; 1981 Apr; 26(4):325-7. PubMed ID: 7238260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
    Pagani A; Zigliani P; Pranzo A; Galante T
    Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sampling variability on percutaneous liver biopsy.
    Abdi W; Millan JC; Mezey E
    Arch Intern Med; 1979 Jun; 139(6):667-9. PubMed ID: 443970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body mass index and liver stiffness affect accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C virus genotype 1 infection.
    Macaluso FS; Maida M; Cammà C; Cabibi D; Alessi N; Cabibbo G; Di Marco V; Craxì A; Petta S
    Clin Gastroenterol Hepatol; 2014 May; 12(5):878-884.e1. PubMed ID: 24112998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
    Yoneda M; Mawatari H; Fujita K; Iida H; Yonemitsu K; Kato S; Takahashi H; Kirikoshi H; Inamori M; Nozaki Y; Abe Y; Kubota K; Saito S; Iwasaki T; Terauchi Y; Togo S; Maeyama S; Nakajima A
    J Gastroenterol; 2007 Jul; 42(7):573-82. PubMed ID: 17653654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.